Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer
PharmaShots
Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2006-2025)Â
Shots: The two decades from 2006 to 2025 reflect one of the most transformative periods in biopharma history, characterized by scientific breakthroughs, strategic consolidation, and remarkable commercial growth. The industry successfully navigated patent expirations, global economic downturns, biosimilar competition, pricing reforms, and the unprecedented COVID-19 pandemic while continuing to deliver innovative therapies. Mergers and acquisitions… The post Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2006-2025) appeared first on PharmaShots.
Read Full Article
Pharma Tech
Bayer banks €3bn in Apollo contraceptives division deal
Bayer's agreement with Apollo comes a little after Bayer broke its pharma dealmaking fast by acquiring Perfuse Therapeutics in May 2026.
Read Full Article
Pharma Tech
Chinese biotech MindRank secures $52m to advance AI-designed oral GLP-1RA
The funds will support the progression of MindRank’s pipeline, which is heavily dominated by obesity indications.
Read Full Article
Pharma Tech
Ipsen set to rival Botox after duo of Phase III migraine wins
Ipsen claims that Dysport has become the first botulinum toxin therapy to demonstrate efficacy in episodic migraine.
Read Full Article
Pharma Tech
Teva and Polpharma Biologics sign global deal for ocrelizumab biosimilar
Teva Pharmaceuticals International and Polpharma Biologics have signed a global licensing agreement for a proposed biosimilar to Ocrevus to treat multiple sclerosis.
Read Full Article
Sponsored content
Featured promotional
News
Latest stories
ET Pharma
Jul 11, 2026, 2:04 AM
US FDA approves Sanofi's wearable injector form of blood cancer drug
The approval boosts the French ​drugmaker as new CEO Belen Garijo seeks to address investor concerns about reliance ​on asthma drug Dupixent, its biggest-selling medicine.
PharmaShots
Jul 10, 2026, 1:30 PM
Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2006-2025)Â
Shots: The two decades from 2006 to 2025 reflect one of the most transformative periods in biopharma history, characterized by scientific breakthroughs, strategic consolidation, and remarkable commercial growth. The industry successfully navigated patent expirations, global economic downturns, biosimilar competition, pricing reforms, and the unprecedented COVID-19 pandemic while continuing to deliver innovative therapies. Mergers and acquisitions… The post Insights+: An Analysis of the Growth of Biopharma Companies in the Last 20 Years (2006-2025) appeared first on PharmaShots.
Pharma Tech
Jul 10, 2026, 1:11 PM
Bayer banks €3bn in Apollo contraceptives division deal
Bayer's agreement with Apollo comes a little after Bayer broke its pharma dealmaking fast by acquiring Perfuse Therapeutics in May 2026.
PharmaShots
Jul 10, 2026, 12:30 PM
Hansoh Reports P-III (ARTEMIS-008) Trial Data on Risvutatug Rezetecan for Advanced or Relapsed SCLC
Shots: Ref: Hansoh |  Image: Hansoh  | Press Release Related News: Hansoh Pharmaceutical Reports the EC Approval of Aumseqa for Non-small Cell Lung Cancer (NSCLC) PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Hansoh Reports P-III (ARTEMIS-008) Trial Data on Risvutatug Rezetecan for Advanced or Relapsed SCLC appeared first on PharmaShots.
PharmaShots
Jul 10, 2026, 11:30 AM
Viz.ai Partners with Cortechs.ai to Expand AI Platform into Neurodegenerative Disease Care
Shots: Ref: Businesswire |  Image: Viz.ai & Cortechs.ai  | Press Release Related News: Viz.ai Enters a Multi-Year Partnership with Sanofi and Regeneron to Improve Management and Care of COPD PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Viz.ai Partners with Cortechs.ai to Expand AI Platform into Neurodegenerative Disease Care appeared first on PharmaShots.
ET Pharma
Jul 10, 2026, 11:11 AM
Bayer gets €3 billion in Apollo deal for contraceptives unit
Apollo funds and affiliates would take a minority, non-controlling stake in a new entity holding the LARC business, while Bayer keeps a majority stake and "complete operational control."
News
Latest industry coverage
Google News
Jul 11, 2026, 4:19 PM
Libtayo Market Competitive Landscape, and Top Industry Participants - EIN Presswire
Libtayo Market Competitive Landscape, and Top Industry Participants  EIN Presswire
Google News
Jul 11, 2026, 4:19 PM
Healthcare Packaging Market Competitive Dynamics, Leading Participants, and Market Expansion Opportunities - EIN Presswire
Healthcare Packaging Market Competitive Dynamics, Leading Participants, and Market Expansion Opportunities  EIN Presswire
Google News
Jul 11, 2026, 4:17 PM
Pharmaceutical Society of Ghana, medical fraternity mourn distinguished pharmacist Dr. Samuel Kwasi Nkansah - Modern Ghana
Pharmaceutical Society of Ghana, medical fraternity mourn distinguished pharmacist Dr. Samuel Kwasi Nkansah  Modern Ghana
Google News
Jul 11, 2026, 4:12 PM
Dr. Samuel Nkansah: Pharmacist, Corporate Leader, And Man Of Faith Laid To Rest - Modern Ghana
Dr. Samuel Nkansah: Pharmacist, Corporate Leader, And Man Of Faith Laid To Rest  Modern Ghana
Google News
Jul 11, 2026, 3:00 PM
Bausch + Lomb ditches BL1107 in glaucoma after trial miss - The Pharma Letter
Bausch + Lomb ditches BL1107 in glaucoma after trial miss  The Pharma Letter
Google News
Jul 11, 2026, 2:18 PM
Swedbank AB Makes New $11.45 Million Investment in Teva Pharmaceutical Industries Ltd. $TEVA - MarketBeat
Swedbank AB Makes New $11.45 Million Investment in Teva Pharmaceutical Industries Ltd. $TEVAÂ Â MarketBeat
Google News
Jul 11, 2026, 2:02 PM
What a US-backed Deal means for the UK Healthcare Industry - Business Chief
What a US-backed Deal means for the UK Healthcare Industry  Business Chief
Google News
Jul 11, 2026, 1:53 PM
Octozi Raises $3 Million Seed To Bring Agentic AI Into Clinical Trial Data Operations - Pulse 2.0
Octozi Raises $3 Million Seed To Bring Agentic AI Into Clinical Trial Data Operations  Pulse 2.0
Google News
Jul 11, 2026, 1:12 PM
Sudan seeks more Indian investment in pharma, healthcare sector - ANI News
Sudan seeks more Indian investment in pharma, healthcare sector  ANI News
Sponsored placement
Featured promotions
Sponsored
Jeplus.in
Purchase All Medicines.Get 10% Offer